Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data

por Dougados, M, Schmidely, N, Le Bars, M, Lafosse, C, Schiff, M, Smolen, J S, Aletaha, D, van Riel, P, Wells, G
Publicado 2008

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to ab...

por Schiff, M, Pritchard, C, Huffstutter, J E, Rodriguez-Valverde, V, Durez, P, Zhou, X, Li, T, Bahrt, K, Kelly, S, Le Bars, M, Genovese, M C
Publicado 2009